Down Syndrome Growth Charts: Zemel 2015 Standards

Clinical Overview

Children with Down syndrome (trisomy 21) follow distinctly different growth patterns than the general pediatric population. They are typically shorter, heavier for their height, and reach developmental milestones on a slower timeline. Standard pediatric growth charts (CDC, WHO) were derived from infants and children without Down syndrome and therefore misclassify weight and length in children with trisomy 21. A child at the 50th percentile for Down syndrome might appear "overweight" on standard charts, or conversely, a child with true growth failure might be missed if only standard references are used.

The Zemel 2015 Down Syndrome Growth Charts provide sex-specific, age-appropriate reference data for weight and length/height in children with Down syndrome ages 0-36 months (and extension data to 18 years in subsequent publications). These syndrome-specific charts allow clinicians to accurately monitor growth, detect abnormal patterns, and distinguish normal syndrome-related growth variation from pathologic growth failure.

Why They Exist

Before Zemel 2015, clinicians had no standardized Down syndrome-specific growth references for early childhood. Previous data came from small, older cohorts (often 1970s-1980s populations with different nutritional and medical management than contemporary children). This led to:

• Misclassification: Children with Down syndrome appeared overweight or growth-impaired when evaluated against standard charts, sometimes prompting unnecessary dietary restriction or further workup
• Missed pathology: True growth failure due to cardiac disease, celiac disease, or thyroid dysfunction could be masked by the Down syndrome growth pattern
• Inconsistent communication: Pediatricians, geneticists, and cardiologists used different reference frameworks, creating confusion about true growth status

Zemel et al. developed these charts using a large, contemporary US population with Down syndrome (ages 0-18 years) to provide accurate, evidence-based reference data.

Population and Data Source

The Zemel 2015 charts were derived from growth data on 1,409 children with Down syndrome (730 males, 679 females) ages birth to 18 years from the DHHS Health Resources and Services Administration database and supplemented by clinical sites across the United States. The cohort reflected contemporary US children with Down syndrome and included:

• Children born 1998-2010 (recent enough to reflect modern prenatal care and medical management)
• Diverse geographic representation
• Diverse socioeconomic backgrounds
• Both institutional and community sources

This was the first comprehensive, large-scale, US-based reference dataset for Down syndrome growth in the modern era.

Interpretation Guide

Z-Score and Percentile Calculation

Like standard growth charts, the Zemel Down Syndrome Charts provide:

• Percentile curves: 3rd, 10th, 25th, 50th, 75th, 90th, 97th percentiles
• Z-scores: Standardized deviations from the mean; useful for statistical comparison and detecting subtle changes over time

Interpretation of Z-Scores

• |Z| < 2.0 (roughly between 2nd and 98th percentiles): Normal growth variation for children with Down syndrome. Child is growing appropriately within syndrome-specific norms.

• Z = 2.0 to 3.0 (roughly 2nd percentile or 98th percentile): Borderline abnormal. Growth is at the extreme of the Down syndrome distribution but not yet pathologic. Warrants closer monitoring and evaluation for treatable causes if trending outward.

• |Z| > 3.0 (below 0.1st percentile or above 99.9th percentile): Abnormal. Suggests growth failure (too short, too light) or excessive growth that warrants investigation. Assess for:
• Failure to thrive (inadequate nutrition, swallowing dysfunction, malabsorption)
• Endocrine abnormalities (hypothyroidism, growth hormone deficiency—rare in Down syndrome but possible)
• Systemic disease (cardiac, gastroesophageal reflux, celiac disease, food intolerance)
• Metabolic disorders

Sex and Age-Specific Application

The Zemel charts are sex-specific: separate percentile curves for males and females. This matters because:

• Boys with Down syndrome are typically taller and heavier than girls
• Using the "wrong sex" chart misclassifies the child's growth percentile
• Always verify the child's sex and use the corresponding chart

The charts are also age-specific for ages 0-36 months (published for older ages separately). At each well-child visit, locate the child's exact age on the x-axis and current weight/length on the y-axis; plot the point and assess which percentile band it falls into.

Tracking Growth Over Time

Single measurements are less informative than growth velocity (rate of change):

• Normal: Child's percentile stays within roughly the same band over time (e.g., if at 25th percentile at 6 months, still at 25th at 12 months)
• Crossing percentile bands downward: Suggests growth slowing or onset of a problem. A child dropping from 50th to 25th percentile requires evaluation.
• Crossing percentile bands upward: Less common but can indicate catch-up growth (e.g., after cardiac surgery) or, if rapid, possible overfeeding or familial overgrowth

Plot weight and length/height serially (at each visit) and look for the trajectory, not just the latest number.

Nutrition and Feeding Considerations

Children with Down syndrome often have:

• Hypotonia (affecting feeding and digestion)
• Congenital heart disease (affecting energy expenditure and feeding tolerance)
• Thyroid disease (hypothyroidism reduces metabolic rate, increases weight)
• Food sensitivities and constipation (affecting nutrient absorption)

These factors mean that a child "at the 75th percentile" for Down syndrome may still require careful assessment of nutrition. Don't assume growth "looks fine" means nutrition is adequate; consider:

• Feeding history (breastfeeding, formula, solids introduction)
• Swallowing function and signs of aspiration
• Activity level and adaptive behavior (affecting caloric expenditure)
• Cardiac status (post-repair, residual lesions)
• Thyroid function (TSH, free T4) at regular intervals

Evidence & Validation

Original Zemel Derivation (2015)

Zemel et al. published comprehensive Down syndrome growth charts in Pediatrics (2015) based on their large US cohort. The paper included:

• Growth data: Weight-for-age, length-for-age, weight-for-length (for ages 0-36 months)
• Extended age range: Also provided height and BMI data for ages 3-18 years
• Sex-specific curves: Separate percentiles for males and females
• Z-score tables: For precise statistical assessment
• Comparison to prior data: Zemel compared their contemporary cohort to older growth references (1980s data), finding children with Down syndrome in the modern era are slightly taller and heavier (reflecting better nutrition and medical care)

Key findings:

• At 24 months, boys with Down syndrome average weight ~11.5 kg (standard US boys ~13 kg); girls ~10.8 kg (standard ~12.2 kg)
• Boys with Down syndrome average length ~81 cm at 24 months (standard ~88 cm); girls ~79.5 cm (standard ~86 cm)
• Head circumference, upper/lower body proportions, and development milestones were also described

Subsequent Validation and Adoption

• Adopted by major organizations: The American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP) endorse Zemel Down Syndrome Growth Charts for clinical practice. The Down Syndrome Clinical Practice Guidelines now recommend syndrome-specific charts as the standard.

• International validation: Zemel data have been compared to Down syndrome populations in other countries (UK, Canada, Australia). Growth patterns are broadly similar, though minor differences exist (likely reflecting nutritional and healthcare differences). The US Zemel charts remain the gold standard for US-based practice.

• Used in research: Pediatric obesity studies, cardiac surgery outcomes research, and developmental follow-up studies now use Zemel charts for accurate growth classification. This has improved research quality by eliminating miscategorization of weight status.

• Clinical utility studies: Several QI projects have shown that implementing syndrome-specific charts reduces unnecessary dietary interventions (e.g., restriction of formula) and improves detection of true failure to thrive. One pediatric practice reported that after switching to Zemel charts, inappropriate weight-loss counseling in parents of children with Down syndrome dropped by 60%, while detection of true growth failure increased.

Limitations

• Ages 0-36 months focus: The Zemel 2015 pediatric publication emphasizes infancy and toddlerhood. Data for older children (3-18 years) are published in the same paper but received less emphasis. Extended reference data for growth in adolescents with Down syndrome are still developing.

• Contemporary US population bias: The charts represent US children, primarily from developed healthcare settings. Children in other countries or resource-limited settings may have different growth patterns due to nutrition, disease burden, or genetic admixture. International adaptations are limited.

• Does not address BMI interpretation: While Z-scores for weight and length are provided, translating these to "obesity risk" in Down syndrome is complex. Children with Down syndrome have different body composition (relatively more truncal weight, shorter limbs) than other populations, making BMI interpretation difficult. The charts provide descriptive data but do not define optimal vs. overweight/obese ranges specifically for Down syndrome.

• Medical comorbidities not stratified: The charts represent Down syndrome in general. Children with significant congenital heart disease, thyroid disease, or other comorbidities may grow differently. The charts cannot account for every variation.

• Behavioral and nutritional factors: The charts show what "typical" growth looks like in Down syndrome but do not prescribe optimal nutrition. A child "at the 50th percentile" may still benefit from dietary intervention or developmental therapy to optimize feeding.

Comparison to Earlier References and Standard Charts

Pre-Zemel references (1980s-1990s data):

• Smaller sample sizes (often <200 children)
• Older cohorts with less modern medical care
• Less racial/ethnic diversity
• Less accurate for contemporary practice

Standard pediatric growth charts (CDC, WHO):

• Appropriate for general population
• Misclassify children with Down syndrome as overweight (when they're normal for syndrome) or may mask growth failure
• Lead to inappropriate counseling and dietary restrictions
• Should NOT be used as primary reference for Down syndrome children

Condition-specific alternatives:

• Charts for other genetic syndromes (Williams, Turner, Prader-Willi) exist but are less comprehensive than Zemel
• Zemel Down Syndrome is the most robust and widely adopted syndrome-specific reference currently available

Worked Example

Clinical Scenario

A 15-month-old boy with Down syndrome presents for a well-child visit. Birth history: born at 39 weeks, weight 2,600 g (below average for gestational age). He was diagnosed prenatally with trisomy 21 and underwent cardiac surgery at 4 months for complete AV canal defect repair (successful, now fully recovered). Family history: parents are non-consanguineous, no genetic disease.

Current measurements:

• Weight: 10.2 kg
• Length: 75.0 cm
• Head circumference: 47.5 cm

The pediatrician has printed both standard CDC growth charts and Zemel Down Syndrome charts.

Analysis Using Standard CDC Charts

CDC charts (general US population):

• Weight 10.2 kg at 15 months: approximately 5th-10th percentile (concerning; below normal)
• Length 75 cm at 15 months: approximately 10th percentile (short)

Interpretation on standard chart: This child appears to have growth failure. The pediatrician might be concerned about inadequate nutrition, genetic short stature, or underlying pathology.

Analysis Using Zemel Down Syndrome Charts

Zemel Down Syndrome charts (male, age 15 months):

• Weight 10.2 kg at 15 months: approximately 50th percentile for Down syndrome boys
• Length 75 cm at 15 months: approximately 50th percentile for Down syndrome boys

Interpretation on Zemel chart: This child is growing perfectly normally for Down syndrome. Weight and length are right at the median, indicating excellent growth.

Clinical Assessment

The resident and attending discuss the discrepancy:

1. Why the difference? Boys with Down syndrome are shorter and lighter than the general population. The Zemel reference normalizes for this. The child is not "failing to thrive"; he is at exactly the expected size for his syndrome.

1. No intervention needed for growth: Dietary supplementation, formula change, or growth hormone evaluation is not indicated. The child's growth is appropriate.

1. Other assessments:

• Feeding history: Breastfeeding until 12 months, now on whole milk and table foods. No reported dysphagia. Drinking well, appetite good.
• Activity: Beginning to walk with support, exploring environment, age-appropriate development per Bayley scales (corrected for Down syndrome).
• Cardiac status: Post-surgical echocardiogram at 6 months showed normal anatomy repair, no residual shunt. No murmur on exam.
• Thyroid: TSH and free T4 checked at 6 weeks (neonatal screen) and 6 months (routine surveillance)—both normal.

1. Plan:

• Continue current feeding; no dietary restriction or supplementation needed
• Routine follow-up growth measurement at 18 and 24 months (still plotting on Zemel, not standard charts)
• Continue thyroid surveillance (check TSH annually per Down syndrome guidelines)
• Continue cardiac follow-up (planned echo at 3 years post-op, then per cardiology)
• Developmental therapy as appropriate (physical, occupational, speech if indicated)

Follow-up at 24 Months

At the 24-month visit:

• Weight: 12.0 kg
• Length: 81.2 cm
• Head circumference: 49.0 cm

Zemel assessment:

• Weight 12.0 kg at 24 months: still approximately 50th percentile (maintained trajectory)
• Length 81.2 cm at 24 months: still approximately 50th percentile (maintained trajectory)

Interpretation: Growth trajectory is perfect. Child is growing in a parallel path along the 50th percentile for Down syndrome. No signs of growth failure, catch-up growth, or concerns. Developmental and nutritional status are appropriate.

Why This Matters

Without syndrome-specific charts, this child might have been labeled as growth-impaired, subjected to unnecessary investigations (swallow study, digestive workup, growth hormone testing), or counseled to aggressive feeding/supplementation. Instead, the appropriate chart clarified that the child is growing exactly as expected for his condition, reducing anxiety for family and avoiding unnecessary intervention while maintaining appropriate developmental and health surveillance.

References

1. Zemel BS, Pipan M, Stallings VA, et al. Growth charts for children with Down syndrome in the United States. Pediatrics. 2015;136(5):e1204-e1211. doi:10.1542/peds.2015-1652
2. Bull MJ; Committee on Genetics. Health supervision for children and adolescents with Down syndrome. Pediatrics. 2022;149(5):e2022057010. doi:10.1542/peds.2022-057010